Genelux Corporation (GNLX)
(Delayed Data from NSDQ)
$2.54 USD
0.00 (0.00%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $2.54 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Income Statements
Fiscal Year end for Genelux Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 11 | 0 | NA | NA |
Cost Of Goods | 0 | 0 | 0 | NA | NA |
Gross Profit | 0 | 11 | 0 | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 24 | 14 | 15 | 0 | 0 |
Income After Depreciation & Amortization | -24 | -3 | -15 | 0 | 0 |
Non-Operating Income | -4 | 0 | -1 | NA | NA |
Interest Expense | 0 | 1 | 1 | NA | NA |
Pretax Income | -28 | -4 | -16 | NA | NA |
Income Taxes | 0 | 1 | 0 | NA | NA |
Minority Interest | 0 | 0 | 0 | NA | NA |
Investment Gains/Losses | 0 | 0 | 0 | NA | NA |
Other Income/Charges | 0 | 0 | 0 | NA | NA |
Income From Cont. Operations | -28 | -5 | -16 | NA | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | NA | NA |
Net Income (GAAP) | -28 | -5 | -16 | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -23 | -2 | -14 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | NA | NA |
Income After Depreciation & Amortization | -24 | -3 | -15 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 24.43 | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.14 | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -1.16 | -0.57 | NA | NA | NA |
Fiscal Year end for Genelux Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 6.90 | 8.12 | 7.00 | 5.31 | 5.39 |
Income After SG&A, R&D, and Dept/Amort Expenses | -6.90 | -8.11 | -7.00 | -5.31 | -5.39 |
Non-Operating Income | 0.32 | 0.27 | 0.24 | -0.04 | -0.40 |
Interest Expense | 0.00 | 0.00 | 0.01 | 0.00 | 0.02 |
Pretax Income | -6.58 | -7.85 | -6.77 | -5.35 | -5.82 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -6.58 | -7.85 | -6.77 | -5.35 | -5.82 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -6.58 | -7.85 | -6.77 | -5.35 | -5.82 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 29.69 | 26.85 | 27.33 | 26.21 | 25.07 |
Diluted EPS Before Non-Recurring Items | -0.22 | -0.29 | -0.25 | -0.20 | -0.21 |
Diluted Net EPS (GAAP) | -0.22 | -0.29 | -0.20 | -0.20 | -0.23 |